Pérez-López, M E <br/><br/>
Ki-67 is a prognostic marker for hormone receptor positive tumors.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  Oct 2016 
 - 996-1002 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-015-1472-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adenocarcinoma, Mucinous--metabolism<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--metabolism<br/>Carcinoma, Ductal, Breast--metabolism<br/>Carcinoma, Lobular--metabolism<br/>Carcinoma, Medullary--metabolism<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Ki-67 Antigen--metabolism<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Prognosis<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Survival Rate